Skip to main content
. Author manuscript; available in PMC: 2020 Oct 19.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2019 Jun 3;46(9):1940–1951. doi: 10.1007/s00259-019-04347-y

Fig 6.

Fig 6

PET-CT imaging and ex vivo biodistribution of 89ZrG4(DFO)3(Bdiol)110. A - representative whole body volume rendered PET-CT images recorded 1 h and 24 h post infusion of 89ZrG4(DFO)3(Bdiol)110 for OBBBO/AI, AI/BBBI and IV/OBBBO infusions; B - ex vivo biodistribution of 89ZrG4(DFO)3(Bdiol)110 at 24 h after infusion in the same mice (insert - scale was adjusted to show brain accumulation of 89ZrG4(DFO)3(Bdiol)110, indication lack of 89ZrG4(DFO)3(Bdiol)110 retention on the brain regardless method of administration and its renal clearance with minor hepatic uptake